Skip to content

Opening book details…

About this Medicine article

Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses by Arodola, Olayide A. (author);Soliman, Mahmoud E.S. (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Arodola, Olayide A. (author);Soliman, Mahmoud E.S. (author)
Publisher
Dove Medical Press Ltd.
Published
2015
Field
Medicine (Health Sciences)